Application of Assessment Scales in Palliative Care for Glioma: A Systematic Review.
- Author:
Zhi-Yuan XIAO
1
;
Tian-Rui YANG
1
;
Ya-Ning CAO
1
;
Wen-Lin CHEN
1
;
Jun-Lin LI
1
;
Ting-Yu LIANG
1
;
Ya-Ning WANG
1
;
Yue-Kun WANG
1
;
Xiao-Peng GUO
1
;
Yi ZHANG
1
;
Yu WANG
1
;
Xiao-Hong NING
2
;
Wen-Bin MA
3
Author Information
- Publication Type:Systematic Review
- Keywords: assessment scales; glioma; palliative care; systematic review
- MeSH: Humans; Glioma/psychology*; Palliative Care/methods*; Quality of Life; Psychometrics; Brain Neoplasms/psychology*
- From: Chinese Medical Sciences Journal 2025;40(3):211-218
- CountryChina
- Language:English
- Abstract: BACKGROUND AND OBJECTIVE: Patients with glioma experience a high symptom burden and have diverse palliative care needs. However, the assessment scales used in palliative care remain non-standardized and highly heterogeneous. To evaluate the application patterns of the current scales used in palliative care for glioma, we aim to identify gaps and assess the need for disease-specific scales in glioma palliative care. METHODS: We conducted a systematic search of five databases including PubMed, Web of Science, Medline, EMBASE, and CINAHL for quantitative studies that reported scale-based assessments in glioma palliative care. We extracted data on scale characteristics, domains, frequency, and psychometric properties. Quality assessments were performed using the Cochrane ROB 2.0 and ROBINS-I tools. RESULTS: Of the 3,405 records initially identified, 72 studies were included. These studies contained 75 distinct scales that were used 193 times. Mood (21.7%), quality of life (24.4%), and supportive care needs (5.2%) assessments were the most frequently assessed items, exceeding half of all scale applications. Among the various assessment dimensions, the Distress Thermometer (DT) was the most frequently used tool for assessing mood, while the Short Form-36 Health Survey Questionnaire (SF-36) was the most frequently used tool for assessing quality of life. The Mini Mental Status Examination (MMSE) was the most common tool for cognitive assessment. Performance status (5.2%) and social support (6.8%) were underrepresented. Only three brain tumor-specific scales were identified. Caregiver-focused scales were limited and predominantly burden-oriented. CONCLUSIONS: There are significant heterogeneity, domain imbalances, and validation gaps in the current use of assessment scales for patients with glioma receiving palliative care. The scale selected for use should be comprehensive and user-friendly.
